Back to top
more

Shandong Weigao Medical Polymer Co. (SHWGF)

(Delayed Data from OTC)

$0.96 USD

0.96
NA

0.00 (0.00%)

Updated Dec 15, 2023 01:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (103 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for SHWGF

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Shandong Weigao Medical Polymer Co falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents -99,999 1,196 1,212 916 721
Receivables NA 1,054 950 879 705
Notes Receivable NA 93 66 34 217
Inventories NA 344 269 218 180
Other Current Assets NA 0 0 0 0
Total Current Assets NA 2,688 2,498 2,047 1,823
Net Property & Equipment NA 963 907 793 746
Investments & Advances NA 275 220 193 212
Other Non-Current Assets NA 31 56 43 113
Deferred Charges NA 24 24 20 15
Intangibles NA 797 798 747 820
Deposits & Other Assets NA 78 130 56 21
Total Assets NA 4,933 4,707 3,962 3,809
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 0 0 0 21
Accounts Payable NA 649 613 545 468
Current Portion Long-Term Debt NA 143 93 43 132
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 27 23 18 18
Other Current Liabilities NA 59 60 45 18
Total Current Liabilities NA 882 793 652 659
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 40 48 49 47
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 505 382 435 642
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 7 235 158 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,449 1,466 1,297 1,350
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 68 71 66 65
Capital Surplus NA 408 425 373 373
Retained Earnings NA 2,599 2,373 1,975 1,764
Other Equity NA 410 371 251 257
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 3,484 3,241 2,665 2,459
Total Liabilities & Shareholder's Equity NA 4,933 4,707 3,962 3,809
Total Common Equity 0 3,484 3,241 2,665 2,459
Shares Outstanding NA 4,520.00 4,520.00 4,522.30 4,522.30
Book Value Per Share 0.00 0.77 0.72 0.59 0.54

Fiscal Year End for Shandong Weigao Medical Polymer Co falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 -99,999 -99,999 -99,999 1,104
Receivables NA NA NA NA 1,164
Notes Receivable NA NA NA NA 77
Inventories NA NA NA NA 329
Other Current Assets NA NA NA NA NA
Total Current Assets NA NA NA NA 2,674
Net Property & Equipment NA NA NA NA 957
Investments & Advances NA NA NA NA 275
Other Non-Current Assets NA NA NA NA 20
Deferred Charges NA NA NA NA 20
Intangibles NA NA NA NA 781
Deposits & Other Assets NA NA NA NA 39
Total Assets NA NA NA NA 4,839
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA NA NA NA
Accounts Payable NA NA NA NA 740
Current Portion Long-Term Debt NA NA NA NA 126
Current Portion Capital Leases NA NA NA NA NA
Accrued Expenses NA NA NA NA NA
Income Taxes Payable NA NA NA NA 26
Other Current Liabilities NA NA NA NA 46
Total Current Liabilities NA NA NA NA 942
Mortgages NA NA NA NA NA
Deferred Taxes/Income NA NA NA NA 35
Convertible Debt NA NA NA NA NA
Long-Term Debt NA NA NA NA 474
Non-Current Capital Leases NA NA NA NA NA
Other Non-Current Liabilities NA NA NA 11
Minority Interest (Liabilities) NA NA NA NA NA
Total Liabilities NA NA NA NA 1,477
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA NA NA NA
Common Stock (Par) NA NA NA NA 65
Capital Surplus NA NA NA NA 391
Retained Earnings NA NA NA NA 2,626
Other Equity NA NA NA NA 280
Treasury Stock NA NA NA NA NA
Total Shareholder's Equity NA NA NA NA 3,362
Total Liabilities & Shareholder's Equity NA NA NA NA 4,839
Total Common Equity 0 0 0 0 103,361
Shares Outstanding NA NA NA NA 4,520.00
Book Value Per Share 0.00 0.00 0.00 0.00 22.87